Neogenomics
NEO
Neogenomics (NEO) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Needham | Maintained | Buy | $19.00 from $15.00 | Jul 29, 2026 |
| Benchmark | Maintained | Buy | $16.00 from $11.00 | Jul 24, 2026 |
| Leerink Partners | Upgraded | Market Perform → Outperform | $25.00 from $12.00 | Apr 29, 2026 |
| TD Cowen | Maintained | Buy | $14.00 from $13.00 | Apr 29, 2026 |
| Benchmark | Upgraded | Hold → Buy | $11.00 | Apr 29, 2026 |
| Piper Sandler | Maintained | Overweight | $13.00 from $12.00 | Feb 24, 2026 |
| Needham | Maintained | Buy | $15.00 from $14.00 | Feb 17, 2026 |
| Needham | Maintained | Buy | $14.00 | Jan 12, 2026 |
| TD Cowen | Maintained | Buy | $12.00 from $10.00 | Sep 12, 2025 |
| Stephens & Co. | Maintained | Overweight | $11.00 from $6.50 | Sep 2, 2025 |
| Needham | Maintained | Buy | $14.00 from $8.00 | Aug 29, 2025 |
| Piper Sandler | Maintained | Overweight | $11.00 from $12.00 | Aug 4, 2025 |
| Morgan Stanley | Maintained | Equal-Weight | $8.00 from $10.00 | Jul 30, 2025 |
| William Blair | Downgraded | Outperform → Market Perform | — | Jul 29, 2025 |
| Needham | Maintained | Buy | $8.00 from $8.50 | Jul 29, 2025 |
| Piper Sandler | Maintained | Overweight | $12.00 from $18.00 | May 6, 2025 |
| Morgan Stanley | Maintained | Equal-Weight | $10.00 from $17.00 | May 1, 2025 |
| Leerink Partners | Downgraded | Outperform → Market Perform | $9.00 from $25.00 | Apr 30, 2025 |
| Goldman Sachs | Maintained | Buy | $10.00 from $15.00 | Apr 30, 2025 |
| Needham | Maintained | Buy | $8.50 from $18.00 | Apr 29, 2025 |
Frequently asked questions
What is the latest analyst rating on NEO?
On Jul 29, 2026, Needham maintained Neogenomics at Buy with a price target of $19.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.